Marsh JC, Bacigalupo A, Schrezenmeier H, et al. Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party. Blood. 2012;119(23):5391-5396.

On page 5391 in the 7 June 2012 issue, the byline and author affiliations omit the twelfth author, Britta Höchsmann. The corrected byline and author affiliations are shown below.

The Authorship Contribution on page 5395 should have read, “J.C.M. was the principal investigator for this study and wrote the paper; J.C.M., J.R.P., A.T., H.S., G.S., and A. Bacigalupo designed the study and performed investigations; J.C.M., A. Bacigalupo, H.S., A.T., A.M.R., J.R.P., M.A., B.H., C.D., S.B.K., A. Barrois, T.H.B., A.J.W., A.F., P.S., R.O., A.R., S.K., G.J.M., and G.S. analyzed data and wrote the paper; R.O., A. Barrois, and P.S. analyzed data; S.K. performed the in vitro studies; J.C.M., A. Bacigalupo, A.T., J.R.P., S.B.K., A.R., A.F., A.J.W., M.A., H.A.A.-Z., B.H., T.F., M.O.E., G.J.M., and G.S. recruited patients; and P.S., A. Bacigalupo, R.O., and A. Barrois performed statistical analysis.”

Judith C. Marsh,¹ Andrea Bacigalupo,² Hubert Schrezenmeier,³ Andre Tichelli,⁴ Antonio M. Risitano,⁵ Jakob R. Passweg,⁴ Sally B. Killick,⁶ Alan J. Warren,⁷ Theodora Foukaneli,⁷ Mahmoud Aljurf,⁸ H. A. Al-Zahrani,⁸ Britta Höchsmann,³ Philip Schafhausen,⁹ Alexander Roth,¹⁰ Anke Franzke,¹¹ Tim H. Brummendorf,¹² Carlo Dufour,¹³ Rosi Oneto,¹⁴ Philip Sedgwick,¹⁵ Alain Barrois,¹⁶ Shahram Kordasti,¹ Modupe O. Elebute,¹ Ghulam J. Mufti,¹ and Gerard Socie,¹⁷ on behalf of the European Blood and Marrow Transplant Group Severe Aplastic Anaemia Working Party

¹Department of Haematological Medicine, King's College Hospital/King's College London, London, United Kingdom; ²Department of Hematology II, Azienda Ospedaliera Universitaria San Martino, Genoa, Italy; ³Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service and University of Ulm, Ulm, Germany; ⁴Department of Hematology, University Hospital, Basel, Switzerland; ⁵Department of Biochemistry and Medical Biotechnology, Hematology, Federico II University of Naples, Naples, Italy; ⁶Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom; ⁷Department of Haematology, University of Cambridge, Cambridge, United Kingdom; ⁸Adult Hematology/HSCT Oncology Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; ⁹Department of Oncology and Hematology, University Cancer Centre Hamburg, Hamburg, Germany; ¹⁰Department of Hematology, West German Cancer Center, University Hospital Essen, Essen, Germany; ¹¹Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany; ¹²Department of Hematology and Oncology, University Hospital of the Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany; ¹³Hematology Unit G. Gaslini Childrens’ Research Hospital, Genova, Italy; ¹⁴Department of Hematology II, Azienda Ospedaliera Universitaria San Martino, Genoa, Italy; ¹⁵Centre for Medical and Healthcare Education, St George’s, University of London, London, United Kingdom; ¹⁶European Blood and Marrow Transplant Clinical Trials Office, Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands; and ¹⁷Hospital Saint Louis, Hematology-Transplantation and Université Paris VII, Paris, France